Echo’s team is at the heart of its mission.
Echo believes that technology is only as powerful as the people behind it. Our team is comprised of leaders in tech, medicine and software application.
Chief Financial Officer
Alan W. Schoenbart, CPA, a senior executive with more than thirty years of financial management experience, joined Echo from Hudson News Distributors, LLC where he most recently served as CFO. Prior to that, Mr. Schoenbart served as the CFO for Forticell Bioscience, Inc., a publicly-traded medical device company with an FDA approved product attempting to develop a cryopreserved version of the product. Mr. Schoenbart has also held prior CFO positions at Vizacom Inc. and Windswept Environmental Group, Inc. Prior to that, he was an audit manager at KPMG LLP in Short Hills, New Jersey. Mr. Schoenbart received his B.S. degree in Accounting from Fairleigh Dickinson University and is a certified public accountant licensed in the State of New York and the State of New Jersey.
Dr. Michael Goldberg
Michael M. Goldberg, M.D. currently serves as Chairman of our Board of Directors, since February, 2015, and most recently served as director since June 2014. Dr. Goldberg is managing partner of Montaur Capital Partners, an investment firm, a position he has held since January 2007. Dr. Goldberg is also CEO of Macrophage Therapeutics, a position held since December 2014. From August 1990 to January 2007, Dr. Goldberg was chairman and chief executive officer of Emisphere Technologies, Inc., a biopharmaceutical company. Prior to this, Dr. Goldberg was a vice president for The First Boston Corporation, where he was a founding member of the Healthcare Banking Group. He received a B.S. from Rensselaer Polytechnic Institute, an M.D. from Albany Medical College of Union University and an M.B.A. from Columbia University Graduate School of Business. Dr. Goldberg also serves on the board of directors of Navidea Biopharmaceuticals and Urigen, a private company.
Mr. Goldberg joined our Board of Directors in June 2014. As a Principal at SMG Consulting, Mr. Goldberg currently provides management consulting for small and medium size businesses. Mr. Goldberg recently served as Chief Executive Officer and Director at Cordex Pharma, Inc., a specialty pharmaceutical company developing new cardiovascular medicines. Prior to joining Cordex, Mr. Goldberg served as Senior Vice President, Operations and Office of the President, at Emisphere Technologies, Inc., a publicly traded biopharmaceutical company charting new frontiers in drug delivery. Prior to that, Mr. Goldberg was President of Hydrovalve Co. Inc., a privately held manufacturing/distribution business with national and international catalog sales. Mr. Goldberg currently serves on the board of Forticell Bioscience, Inc. He received his Bachelor of Science degree in Electrical Engineering and Computer Sciences from the NYU School of Engineering (Previously the Polytechnic Institute of New York) and a Master in Business Administration in Marketing from Adelphi University.